Cite
APA Citation
Rowan, C. R., Keegan, D., Byrne, K., Cullen, G., Mulcahy, H. E., Sheridan, J., Ryan, E. J., de Vries, A., D'Haens, G., & Doherty, G. A. (2018). subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study. Alimentary pharmacology & therapeutics, 48(3), 333–339. http://access.bl.uk/ark:/81055/vdc_100066534480.0x000045